Apnimed, Inc. (APMD)

29.00 +0.89 (+3.17%) USD  |  NASDAQ  |  Sep 18, 16:00
29.40 +0.40 (+1.38%) Pre-Market: 09:19
More

Apnimed Shareholders Equity (Quarterly) : 69.76M for June 30, 2026

Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for APMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 69.76M
Date Value
March 31, 2026 -58.18M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
IGC Pharma, Inc. 6.132M
Cocrystal Pharma, Inc. 1.044M
CNBX Pharmaceuticals, Inc. -2.660M
GB Sciences, Inc. --
Arvinas, Inc. 562.20M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 195.46M
Total Liabilities (Quarterly) 125.70M
Debt to Equity Ratio 1.152
Current Ratio 5.059